RPCONE
TMO icon

Retirement Planning Company of New England’s Thermo Fisher Scientific TMO Stock Holding History

Retirement Planning Company of New England’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$487K Buy
971
+31
+3% +$14.9K 0.18% 143
2026
Q1 		$462K Buy
940
+85
+10% +$46.1K 0.19% 137
2025
Q4 		$495K Sell
855
-7
-0.8% -$3.96K 0.2% 129
2025
Q3 		$418K Buy
862
+13
+2% +$6.05K 0.17% 154
2025
Q2 		$344K Buy
849
+100
+13% +$41.8K 0.15% 166
2025
Q1 		$373K Buy
749
+13
+2% +$7.04K 0.19% 145
2024
Q4 		$383K Buy
736
+14
+2% +$7.7K 0.19% 139
2024
Q3 		$447K Sell
722
-16
-2% -$9.47K 0.22% 129
2024
Q2 		$408K Sell
738
-42
-5% -$24.1K 0.22% 129
2024
Q1 		$453K Sell
780
-4
-0.5% -$2.25K 0.25% 118
2023
Q4 		$416K Buy
784
+251
+47% +$121K 0.19% 132
2023
Q3 		$270K Sell
533
-101
-16% -$53.8K 0.15% 145
2023
Q2 		$331K Buy
634
+24
+4% +$13K 0.19% 142
2023
Q1 		$351K Buy
610
+13
+2% +$7.33K 0.21% 137
2022
Q4 		$329K Sell
597
-12
-2% -$6.36K 0.21% 137
2022
Q3 		$308K Sell
609
-1
-0.2% -$560 0.22% 140
2022
Q2 		$331K Buy
610
+23
+4% +$12.7K 0.23% 132
2022
Q1 		$347K Buy
587
+261
+80% +$150K 0.2% 145
2021
Q4 		$217K Buy
+326
New +$204K 0.11% 206

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Retirement Planning Company of New England's TMO Position: Q2 2026 in Review

Retirement Planning Company of New England increased its Thermo Fisher Scientific (TMO) stake by 3.3% in Q2 2026, buying an estimated $14.9K and bringing the position to 971 shares worth $487K. The position accounts for 0.18% of the portfolio, ranked #143.

Retirement Planning Company of New England first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $495K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Retirement Planning Company of New England held 971 shares of Thermo Fisher Scientific worth $487K as of Q2 2026.
  • Retirement Planning Company of New England bought 31 Thermo Fisher Scientific shares in Q2 2026, an estimated $14.9K.
  • Thermo Fisher Scientific made up 0.18% of Retirement Planning Company of New England's portfolio in Q2 2026, its #143 holding.
  • Retirement Planning Company of New England first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • Retirement Planning Company of New England's Thermo Fisher Scientific position peaked at $495K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Retirement Planning Company of New England's 13F filing for Q2 2026, filed 30 Jul 2026.